Clinical Trials Browser

N-monoacetylcystine × 30 days × Clear all

NCT04481048 2026-06-05

DoDNAC

Phase 2 Completed

25 enrolled 12 charts

Attention Deficit Disorder with Hyperactivity, Neurofibromatosis 1